January 31, 2018 (HealthDay News) Single infusion provided durable remission with long-term persistence in pediatric, young adult patients A single infusion of the anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, …
Tisagenlecleucel Beneficial for Youth With Refractory B-Cell ALL Read More
Here are some links to studies that have recently come out on CAR T-Cell. These are obtainable only by a paid subscription to the journal. March 2018 Apoptotic Cells Dramatically …
Other Studies on CAR T-Cell Therapy Read More
Stephen M. Ansell, MD. PhD. and Radhakrishnan Ramchandren, MD discuss the Zuma 1 trial on pretreated large cell lymphoma. The CAR T-cell treatment showed a 60% to 70% response rates …
Investigating CAR T-Cell Therapy in Lymphoma Read More
Dr. Cohen describes what to expect in 2018 in the area of CAR T cell therapy, one of the most exciting new modalities for the treatment of multiple myeloma.
CAR-T cell therapy and what to look for in 2018 Read More
Published September 18, 2017 CAR T-cell therapy is a revolutionary immunotherapy treatment that supercharges a patient’s own blood cells to seek out and destroy cancer cells. Thanks to CAR T-cell …
VIDEO: CAR T-cell Therapy for Pediatric Leukemia: Sam’s Story Read More
Published on August 31, 2011 Researchers at Penn’s Abramson Cancer Center have molecularly engineered T-cells from patients with chronic lymphocytic leukemia and achieved an exceptional, unprecedented antitumor response. In the …
VIDEO: Genetically Modified T Cells Obliterate Chronic Lymphocytic Leukemia Tumors Read More
“The U.S. Food and Drug Administration’s Oncologic Drugs Advisory Committee unanimously voted to recommend approval for CTL019, an experimental cancer drug that belongs to a class of drugs called CAR …
July 12, 2017 – Novartis CAR-T Cell Therapy One Step Closer to FDA Approval Read More
Published on Aug 4, 2017 Gail Roboz, MD, a professor of Medicine and director of the Clinical and Translational Leukemia Program at Weill Cornell Medicine/NewYork-Presbyterian Hospital, discusses the challenges clinicians …
VIDEO: Dr. Roboz on Challenges With CAR T-cell Therapy in ALL Read More
Published on Jul 21, 2017 Ezra Cohen, MD, associate director, Moores Cancer Center at the University of California, San Diego, discusses CAR T-cell therapy for patients with head and neck …
VIDEO: CAR T-Cell Therapy in Head and Neck Cancer Read More
July 6, 2017 (ecancer) Dr Lin speaks with ecancer at EHA 2017 about clinical and biologic outcomes in patients with refractory aggressive Non-Hodgkin Lymphoma (NHL) treated with CAR T cell …
VIDEO: ZUMA1 trial of CD19 CAR T cells for aggressive NHL Read More